Prudential Financial Inc. increased its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 177.7% in the ...

Raymond James Financial Inc. bought a new position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) in the fourth ...

Xenon Pharmaceuticals Inc.'s XEN1101 shows promise in epilepsy with strong phase 2b results and solid financials. Click here ...

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares lost ground Friday, as the neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing ...

Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meetingLong-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in focal onset ...

Mike Patterson, Curium's North American Chief Executive Officer said: "Customers are looking to simplify their business. Our ...

Austrian guide Lukas Furtenbach will lead a one-week trip to the top of Everest and back this year. Prior to the ascent, he ...

ISRO has successfully completed a 1,000-hour life test for its 300mN Stationary Plasma Thruster, designed for the Electric ...

According to Future Market Insights (FMI), the global rare gas industry is expected to grow at a 5.1% CAGR, reaching USD 6.5 billion by 2034.

Teresa Marrodán Undagoitia has been appointed as professor by special appointment in Novel Detection and Analysis Techniques ...

A live audio webcast of the company presentation will be available on the “Investors” section of Xenon’s website and posted for replay following the event. The above listed dates and times are subject ...